enGene Therapeutics Inc. Common Stock (ENGN) News

Latest headlines that mention ENGN, newest first · each headline opens the original publisher

ENGN quote

Last price: $1.63
Day change: -2.40%
Next earnings: —

Quote & chart Expected move Insider trading IV rank history

ENGN headlines

latest coverage

Seeking Alpha News 2d ago

enGene Therapeutics Inc. (ENGN) Discusses Preclinical Data and Clinical Case Studies on Incorporating Surfactant Bladder Rinse into Treatment - Slideshow

General T2ENGN

Investing.com 5d ago

H.C. Wainwright reiterates Engene stock rating on NMIBC data

General T3ENGN

Seeking Alpha News 6d ago

enGene Therapeutics Inc. (ENGN) Discusses Preclinical Data and Clinical Case Studies on Incorporating Surfactant Bladder Rinse into Treatment Transcript

General T2ENGN

Seeking Alpha News 1mo ago

enGene Therapeutics Inc. (ENGN) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

General T2ENGN

Seeking Alpha News 1mo ago

enGene Therapeutics: Slashing Cash Burn To Bring Their Asset To The Market

General T2ENGN

Investing.com 1mo ago

Engene Holdings stock rating maintained at Market Perform by Citizens

General T3ENGN

Seeking Alpha 1mo ago

enGene Holdings GAAP EPS of -$0.47 misses by $0.04

Earnings T2ENGN

Seeking Alpha News 2mo ago

enGene Therapeutics Inc. (ENGN) Discusses Market Insights and Clinical Development in Non-Muscle Invasive Bladder Cancer Transcript

General T2ENGN

Seeking Alpha News 2mo ago

enGene Therapeutics Inc. (ENGN) Discusses Market Insights and Clinical Development in Non-Muscle Invasive Bladder Cancer - Slideshow

General T2ENGN

Investing.com 4mo ago

Morgan Stanley cuts Engene stock rating on reduced sales outlook

General T3ENGN MS

Yahoo Finance 4mo ago

Neumora depression drug fails; EnGene to cut 50% of staff

General T2ENGN NMRA

Seeking Alpha 4mo ago

enGene Holdings GAAP EPS of $0.43

Earnings T2ENGN

Seeking Alpha News 4mo ago

enGene Therapeutics: The Selloff Creates An Opportunity

Markets T2ENGN

Investing.com 5mo ago

Form 13G enGene Holdings Inc. For: 13 May

General T3ENGN

Seeking Alpha News 5mo ago

enGene Therapeutics Inc. (ENGN) Discusses Pivotal Cohort Data from LEGEND Trial of Detalimogene in High-Risk NMIBC Transcript

General T2ENGN

Seeking Alpha News 5mo ago

enGene Therapeutics Inc. (ENGN) Discusses Pivotal Cohort Data from LEGEND Trial of Detalimogene in High-Risk NMIBC - Slideshow

General T2ENGN

Investing.com 5mo ago

Engene stock rating cut to Perform by Oppenheimer on trial data

General T3ENGN OPY

Investing.com 5mo ago

Guggenheim downgrades Engene stock rating on weaker trial data

General T3ENGN

ENGN news alerts

Get an alert by email or push when a new headline mentions ENGN.

More news

News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.